Kris Thiruvillakkat

Senior Director, Global Evidence Market Access & Pricing at CSL Behring

Speaker

Kris has biopharma expertise from ‘first time in human’ clinical stage gate through molecule ‘loss of exclusivity’ global market access strategy, planning and operations including pricing, reimbursement, contracting, tendering, health economics outcomes research, real world evidence, access-related policy, business development and negotiations. He has particular business and scientific acumen within domain of specialty biopharmaceuticals for immunology, hematology, vaccinology, oncology, critical care and transplant medicine benefiting population health to rare disease communities.